| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $950 | +5.4% |
| R&D Expense | $40K | +28.5% |
| SG&A Expense | $4.4M | +835.1% |
| Operating Income | -$4.5M | -633.1% |
| Pre-tax Income | -$4.7M | -651.2% |
| Income Tax | $0 | — |
| Net Income | -$4.7M | -651.2% |
| EPS (Basic) | -$1.51 | -184.9% |
| EPS (Diluted) | -$1.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $5.9M | +629.6% |
| Total Assets | $6.2M | -90.5% |
| Total Liabilities | $1.9M | +1465.3% |
| Stockholders' Equity | $4.3M | +530.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -769.8% |
| Investing Cash Flow | -$368K | -1.1% |
| Financing Cash Flow | $9.1M | +639.9% |
| -184.9% |